© 2022 MJH Life Sciences and Medical Economics. All rights reserved.
© 2022 MJH Life Sciences™ and Medical Economics. All rights reserved.
More than 1,000 physicians participated in the annual survey.
Criteria and types of health care professionals who may screen patients at high risk for cardiovascular disease.
Recommendations for establishing relationships and talking with patients about primary and secondary prevention against cardiovascular events.
Muthiah Vaduganathan, MD, MPH, presents a case study for a patient hospitalized with heart failure whose therapy was optimized with an SGLT-2 inhibitor.
A panel of experts provide clinical pearls for primary care providers who manage patients with diabetes and cardiovascular comorbidities.
Robert Busch, MD, provides an overview of the clinical trials supporting improved cardiovascular disease outcomes in patients with and without diabetes.